Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4’852 JPY | -0.16% | -1.40% | -9.17% |
25.04. | Muttergesellschaft von Chugai Pharmaceutical, Roche, verzeichnet geringere Verkäufe in Q1; Aktie fällt um 5% | MT |
24.04. | Gewinn von Chugai Pharmaceutical in Q1 leicht gestiegen | MT |
ETFs investiert in Chugai Pharmaceutical Co., Ltd
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
6,57% | 15 M€ | +7.34% | ||
1,87% | 60 M€ | +14.42% | ||
1,59% | 4 M€ | +13.95% | ||
1,53% | 67 864 M€ | +14.28% | ||
1,32% | 31 732 M€ | +14.31% | - | |
1,31% | 1 198 M€ | +13.48% | - | |
1,28% | 11 M€ | +10.37% | - | |
1,22% | 16 729 M€ | +13.38% | - | |
1,13% | 15 M€ | +14.10% | ||
1,11% | 251 M€ | +13.17% | ||
1,09% | 51 M€ | -.--% | - | |
1,09% | 174 M€ | -.--% | - | |
1,08% | 26 M€ | +20.62% | ||
0,77% | 81 M€ | +14.05% | ||
0,70% | 73 M€ | +11.61% | ||
0,54% | 14 M€ | +15.63% | ||
0,51% | 10 207 M€ | +14.32% | ||
0,51% | 5 115 M€ | +13.58% | ||
0,49% | 267 M€ | +5.99% | ||
0,44% | 18 M€ | +16.15% | - | |
0,37% | 20 721 M€ | +13.52% | - | |
0,37% | 66 066 M€ | +14.68% | - | |
0,37% | 144 586 M€ | +14.49% | ||
0,35% | 717 M€ | +6.20% | ||
0,24% | 36 M€ | +1.20% | - | |
0,14% | 2 M€ | -.--% | - | |
0,14% | 2 M€ | +9.19% | - | |
0,14% | 21 M€ | +0.22% | - | |
0,11% | 10 M€ | -3.35% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-9.17% | 50.71 Mrd. | |
+25.83% | 661 Mrd. | |
+27.00% | 566 Mrd. | |
-6.76% | 352 Mrd. | |
+20.34% | 332 Mrd. | |
+3.00% | 283 Mrd. | |
+13.09% | 231 Mrd. | |
+5.46% | 200 Mrd. | |
-9.61% | 195 Mrd. | |
-6.26% | 145 Mrd. |
- Börse
- Aktien
- 857216 Aktie
- ETFs Chugai Pharmaceutical Co., Ltd